查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2047985

皮膚替代品市場：全球產業規模、市場佔有率、趨勢、機會和預測（按類型、應用、最終用戶和地區分類）、競爭格局（2021-2031 年）

Skin Substitutes Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球皮膚替代品（皮膚替代品）市場預計將從 2025 年的 4.1426 億美元成長到 2031 年的 6.9018 億美元，複合年成長率為 8.88%。

這些產品是生物工程或合成組織結構，旨在取代或修復受損皮膚，提供臨時或永久性保護層以促進創傷治療。市場成長的主要驅動力是慢性疾病（尤其是糖尿病）盛行率的不斷上升。糖尿病是導致難癒合傷口（例如糖尿病足潰瘍）發生的因素。此外，人口老化和嚴重燒傷事故的持續發生也增加了對有效創傷護理管理的需求，從而導致對這些再生醫學解決方案的需求不斷成長。儘管需求強勁，但市場仍存在許多障礙，例如高昂的治療費用和複雜的保險報銷體系，阻礙了患者獲得這些至關重要的治療方法。鑑於需要高級護理的患者數量不斷增加，這項經濟挑戰尤為嚴峻。例如，根據國際糖尿病聯盟 (IDF) 的數據，到 2024 年，全球將有約 5.89 億成年人患有糖尿病，這是大規模的患者群體，他們容易出現需要皮膚替代干預的慢性傷口。

市場概覽
預測期 2027-2031
市場規模（2025 年） 4.1426億美元
市場規模（2031年） 6.9018億美元
複合年成長率（2026-2031） 8.88%
成長最快的細分市場 慢性傷口
最大的市場 北美洲

市場促進因素

慢性傷口和燒傷的日益普遍是全球皮膚替代物市場的主要促進因素。隨著糖尿病足潰瘍和嚴重燒傷等複雜病症的日益常見，臨床上對促進傷口縫合和組織再生的先進生物工程構建體的需求也日益成長。此外，全球老年人口的成長進一步加劇了這項需求，因為老年人更容易出現難癒合傷口，因此需要有效的治療性介入。近期行業趨勢表明，這群患者對市場滲透率的直接影響顯而易見。 MIMEDX集團公司報告稱，到2025年10月，其傷口護理產品的銷售額將年增40%，這表明患者需求正在轉化為顯著的商業性成長，並增加了對有效癒合解決方案的需求。此外，對再生醫學研發的大量投資也顯著加速了市場擴張。製造商正積極投資開發先進的無細胞和細胞基質，以提高生物相容性並降低排斥率。這些技術進步不僅改善了患者的治療效果，也為主要產業相關人員帶來了顯著的收入成長。例如，Organogenesis Holdings Inc. 報告稱，截至 2025 年 11 月，其淨產品銷售額為 1.505 億美元，這主要得益於其高級創傷護理部門 31% 的成長。同樣，Integra LifeSciences 的組織技術部門累計，截至 2025 年 2 月，其銷售額為 1.28 億美元，表明該專業領域持續的財務擴張。

市場挑戰

全球皮膚替代物市場面臨高昂的治療成本和複雜的報銷系統所帶來的許多挑戰。醫療機構在使用這些先進的生物工程產品時，往往面臨巨大的財務風險，因為保險覆蓋範圍通常不穩定或不足。這種經濟失衡阻礙了昂貴治療方法的普及，導致臨床醫生傾向於選擇更經濟實惠的標準創傷護理方案，即便先進產品在臨床上更為適用。因此，市場成長受到阻礙，商業性應用也遠遠落後於這些解決方案的技術成熟度。政府在這些治療方法上的支出持續成長，進一步加劇了這種財務負擔，給製造商和醫療機構都帶來了不穩定性。例如，創傷護理照護相關人員聯盟在2025年報告中指出，2024年美國聯邦醫療保險B部分在皮膚替代品產品上的支出超過100億美元。如此巨額的支出迫使支付方實施嚴格的固定費率支付方案改革，導致利潤率大幅下降，患者獲得產品的機會也受到限制。儘管慢性傷口的發生率不斷上升，但這些資金限制直接阻礙了市場有效擴張的能力。

市場趨勢

一個關鍵的市場趨勢是，人們越來越傾向於選擇無細胞真皮基質而非合成替代品。這源自於臨床醫師日益重視能夠改善組織整合的生物相容性解決方案。與合成產品不同，這些生物來源的支架保留了吸引宿主細胞的必需結構蛋白，從而加速複雜修復過程中的重塑。這種臨床轉變正推動專注於天然來源軟組織增強產品的公司業績強勁成長。例如，Sanara MedTech Inc.在2025年11月報告稱，其外科軟組織產品的銷售額將達到2,340萬美元，年成長24%，這反映了這些生物技術的快速發展。此外，產品應用擴展到美容和重組外科領域也帶來了巨大的成長機遇，使皮膚替代物的應用範圍不再局限於慢性潰瘍。外科醫生擴大在創傷重組和運動醫學中使用再生基質，在這些領域，最大限度地減少疤痕和最佳化功能恢復至關重要。應用領域的多元化使製造商能夠透過進入急性外科手術市場來降低對慢性傷口領域的依賴。 Organogenesis Holdings Inc. 於 2025 年 8 月發布的一份報告也印證了這一成長趨勢。該報告顯示，該公司「外科與運動醫學」部門的淨銷售額成長了 16%，達到 810 萬美元。這表明，除創傷護理之外，再生醫學產品在其他專業領域的需求也在不斷成長。

目錄

第1章：引言

第2章 分析方法

第3章執行摘要

第4章：客戶心聲

第5章：全球肌膚替代品市場展望

  • 市場規模及預測
    • 以金額為準
  • 市佔率及預測
    • 按類型（生物來源、合成）
    • 依應用領域（急性傷口、慢性傷口）
    • 依最終使用者（醫院/診所、門診手術中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美皮膚替代品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲人造皮膚市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區皮膚替代品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲皮膚替代品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲皮膚替代品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 企業合併（M&A）
  • 產品發布
  • 近期趨勢

第13章：全球皮膚替代品市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客購買力
  • 替代品的威脅

第15章 競爭格局

  • Amarantus BioScience Holdings, Inc
  • Organogenesis Inc.
  • Smith & Nephew Plc.
  • Integra LifeSciences Corporation
  • BSN Medical GmbH
  • Molnlycke Health Care ABss
  • Medtronic Plc
  • Tissue Regenix Ltd.
  • Stratatech Corporation

第16章 策略建議

第17章：關於TSCI與免責聲明

簡介目錄
Product Code: 14831

The global skin substitutes market is projected to expand from USD 414.26 million in 2025 to USD 690.18 million by 2031, exhibiting an 8.88% compound annual growth rate. These products are bioengineered or synthetic tissue constructs designed to replace or repair damaged skin, offering a temporary or permanent protective covering that aids wound healing. The market's growth is largely propelled by the increasing prevalence of chronic diseases, particularly diabetes, which leads to a higher incidence of difficult-to-heal wounds like diabetic foot ulcers. Furthermore, the rising geriatric population and the ongoing occurrence of severe burn injuries continue to drive the need for effective wound care management, thereby boosting demand for these regenerative solutions.Despite this strong demand, the market faces a considerable hurdle due to the high cost of treatment and intricate reimbursement policies, which can restrict patient access to these crucial therapies. This financial challenge is particularly significant given the growing number of patients in need of advanced care. For instance, the International Diabetes Federation reported that in 2024, approximately 589 million adults globally were living with diabetes, representing a substantial population prone to chronic wounds that necessitate intervention with skin substitutes.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 414.26 Million
Market Size 2031USD 690.18 Million
CAGR 2026-20318.88%
Fastest Growing SegmentChronic Wounds
Largest MarketNorth America

Market Driver

The increasing prevalence of chronic wounds and burn injuries is a key driver for the global skin substitutes market. As complex conditions such as diabetic foot ulcers and severe burns become more common, there is a growing clinical need for advanced bioengineered constructs to promote wound closure and tissue regeneration. This demand is further amplified by a growing elderly global population, which is more prone to non-healing wounds and thus requires effective therapeutic interventions. The direct influence of this patient demographic on market adoption is evident in recent industry results, where patient demand is converting into significant commercial growth, as highlighted by MIMEDX Group, Inc. reporting a 40% year-over-year growth in wound product sales in October 2025, emphasizing the escalating need for effective healing solutions.Additionally, substantial investments in regenerative medicine research and development are significantly accelerating market expansion. Manufacturers are actively investing capital in creating advanced acellular and cellular matrices that offer improved biocompatibility and lower rejection rates. These technological advancements are not only enhancing patient outcomes but also generating considerable revenue growth for major industry participants. For instance, Organogenesis Holdings Inc. reported net product revenue of $150.5 million in November 2025, primarily driven by a 31% increase in its advanced wound care segment. Similarly, Integra LifeSciences' Tissue Technologies segment generated $128.0 million in revenue in February 2025, demonstrating sustained financial expansion within this specialized sector.

Market Challenge

The global skin substitutes market faces a significant hurdle due to the high treatment costs and intricate reimbursement policies. Healthcare providers frequently encounter substantial financial risks when using these advanced bioengineered products, often because of uncertain or insufficient payment coverage from insurance providers. This financial discrepancy discourages the adoption of premium therapies, leading clinicians to choose more affordable standard wound care alternatives, even when advanced constructs are clinically more appropriate. As a result, market growth is hampered, with commercial adoption falling considerably behind the technological availability of these solutions.This financial strain is exacerbated by the unsustainable path of government spending on these therapies, which introduces instability for both manufacturers and healthcare facilities. For example, the Alliance of Wound Care Stakeholders reported in 2025 that Medicare Part B expenditures for skin substitute products exceeded $10 billion in 2024. Such considerable spending prompts payers to implement strict flat-rate payment reforms, which severely restrict profit margins and reduce patient access to these products. These fiscal limitations directly impede the market's capacity to expand effectively, despite the increasing incidence of chronic wounds.

Market Trends

A significant market trend is the growing preference for acellular dermal matrices over synthetic alternatives, as clinicians increasingly favor biocompatible solutions that improve tissue integration. Unlike synthetic options, these biological scaffolds retain essential structural proteins that recruit host cells, thereby accelerating the remodeling process during complex repairs. This clinical shift is leading to strong commercial performance for companies focused on naturally derived soft tissue reinforcement. For instance, Sanara MedTech Inc. reported in November 2025 that sales of surgical soft tissue products rose by 24% year-over-year, reaching $23.4 million, which reflects the rapid adoption of these biologic technologies.Moreover, the expansion of product applications into aesthetic and reconstructive surgery represents a crucial growth opportunity, extending the use of skin substitutes beyond just chronic ulcers. Surgeons are increasingly employing regenerative matrices for trauma reconstruction and sports medicine, areas where minimal scarring and optimal functional recovery are critical. This diversification enables manufacturers to reduce reliance on the chronic wound sector by entering acute surgical markets. This growth is evidenced by Organogenesis Holdings Inc.'s report in August 2025, showing that net revenue from its Surgical & Sports Medicine segment increased by 16% to $8.1 million, indicating the growing appeal of regenerative products in specialized non-wound care applications.

Key Market Players

  • Amarantus BioScience Holdings, Inc
  • Organogenesis Inc.
  • Smith & Nephew Plc.
  • Integra LifeSciences Corporation
  • BSN Medical GmbH
  • Molnlycke Health Care ABss
  • Medtronic Plc
  • Tissue Regenix Ltd.
  • Stratatech Corporation

Report Scope

In this report, the Global Skin Substitutes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Skin Substitutes Market, By Type

  • Biological
  • Synthetic

Skin Substitutes Market, By Application

  • Acute Wounds
  • Chronic Wounds

Skin Substitutes Market, By End User

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Skin Substitutes Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Skin Substitutes Market.

Available Customizations:

Global Skin Substitutes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Skin Substitutes Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Biological, Synthetic)
    • 5.2.2. By Application (Acute Wounds, Chronic Wounds)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Skin Substitutes Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Skin Substitutes Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Skin Substitutes Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Skin Substitutes Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Skin Substitutes Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Skin Substitutes Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Skin Substitutes Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Skin Substitutes Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Skin Substitutes Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Skin Substitutes Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Skin Substitutes Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Skin Substitutes Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Skin Substitutes Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Skin Substitutes Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Skin Substitutes Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Skin Substitutes Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Skin Substitutes Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Skin Substitutes Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Skin Substitutes Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Skin Substitutes Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Skin Substitutes Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Skin Substitutes Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Skin Substitutes Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Skin Substitutes Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Skin Substitutes Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Amarantus BioScience Holdings, Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Organogenesis Inc.
  • 15.3. Smith & Nephew Plc.
  • 15.4. Integra LifeSciences Corporation
  • 15.5. BSN Medical GmbH
  • 15.6. Molnlycke Health Care ABss
  • 15.7. Medtronic Plc
  • 15.8. Tissue Regenix Ltd.
  • 15.9. Stratatech Corporation

16. Strategic Recommendations

17. About Us & Disclaimer